Publications by authors named "Leo Xun Yang Hu"
Curr Oncol
September 2022
Article Synopsis
- Real-world data on positive non-small cell lung cancer (NSCLC) patients in Canada is scarce, prompting a study using Alberta's administrative databases to assess mutation prevalence and treatment outcomes.
- From 2013 to 2019, out of 2,974 tested patients, 451 (15.2%) were positive for NSCLC mutations, with Exon 19 mutations being the most common at 49%, followed by L858R at 35.3%, and Exon20ins at 4%.
- Patients with Exon20ins mutations had significantly poorer overall survival outcomes (10.5 months) compared to those with Exon 19 (20.6 months) and L858R mutations (19.1
